VENABLE LLP

Lobbying for GENEOSCOPY · Life sciences company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Missouri · House · Senate · $20,000.00 income · posted Jul 16, 2026

Lobbying activity 2

Health Issues

Increasing access to colorectal cancer screening Medicare coverage of colorectal cancer screening tests USPSTF colorectal cancer screening guidelines Medicare Quality Measures Commercial coverage of colorectal cancer screening

Budget/Appropriations

FY 2027 LHHS Appropriations regarding colorectal cancer screening

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.